Researchers at Karolinska Institutet in Sweden have managed to sequence the giant genome of a salamander, the Iberian ribbed newt, which is a full six times greater than the human genome.
Amongst the early findings is a family of genes that can provide clues to the unique ability of salamanders to rebuild complex tissue, even body parts. The study is published in Nature Communications.
This is the first time that an entire newt genome has been sequenced, an achievement that can give rise to new discoveries on the amphibian’s ability to recreate brain neurons as well as entire body parts. Amongst the first findings are a multitude of copies of a certain microRNA group, which in mammals is mainly found in embryonic stem cells, but also in tumour cells.
“It will be exciting to figure out how regeneration in the adult organism re-activates embryonic genes,” says study leader Professor András Simon at Karolinska Institutet’s Department of Cell and Molecular Biology. “What’s needed now are functional studies of these microRNA molecules to understand their function in regeneration. The link to cancer cells is also very interesting, especially bearing in mind newts’ marked resistance to tumour formation.”
Even though the abundance of stem cell microRNA genes is quite surprising, it alone cannot explain how salamanders regenerate so well. Professor Simon predicts that the explanation lies in a combination of genes unique to salamanders and how other more common genes orchestrate and control the actual regeneration process.
One of the reasons why salamander genomes have not been sequenced before is its sheer size – six times bigger than the human genome in the case of the Iberian newt, which has posed an enormous technical and methodological challenge.
“It’s only now that the technology is available to handle such a large genome,” says Professor Simon. “The sequencing per se doesn’t take that long – it’s recreating the genome from the sequences that’s so time consuming.”
“We all realised how challenging it was going to be,” recounts first author Ahmed Elewa, postdoctoral fellow at the same department. “But the very fact that it was such a challenge made it all the more exciting.”
The group at Karolinska Institutet is now engaging with other researchers to discover what can be learned from the newt genome and test new hypotheses through systematic comparisons with mammals.
“We showed ten years ago that salamanders can recreate all the cells that die in Parkinson’s disease in the space of four weeks,” says Professor Simon. “We can now delve deeply into the molecular processes underlying this ability. Although we’re doing basic research, our findings can hopefully lead to the development of new regenerative strategies for humans.”
The Latest on: Regenerative medicine
- Regenerative Medicine Market Recorded Strong Growth in 2019; COVID-19 Pandemic Set to Drop Saleson May 11, 2020 at 6:47 pm
Analystsat Future Market Insights find that the global Regenerative Medicine market hasbeen evolving at a CAGR of xx%. The market study suggests that the globalmarket size of Regenerative Medicine is ...
- Organogenesis (ORGO) Reports Q1 Loss, Tops Revenue Estimateson May 11, 2020 at 6:04 pm
Organogenesis (ORGO) delivered earnings and revenue surprises of -33.33% and 0.71%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- UCLA researchers develop first roadmap of how human skeletal muscle developson May 11, 2020 at 2:38 pm
An interdisciplinary team of researchers at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at UCLA has developed a first-of-its-kind roadmap of how human skeletal ...
- Regenerative Medicine Market 2020 Focuses on the Global Key Manufacturers, Competition Landscape and SWOT Analysis by 2027on May 8, 2020 at 1:55 am
The research report of the global Regenerative Medicine market provides in-depth insights to ease decision making or to find relevant information. The report comprises various entities inclusive of ...
- Immunicum AB (publ) Receives Regenerative Medicine Advanced Therapy Designation from FDA for Ilixadencel in Kidney Canceron May 5, 2020 at 11:00 pm
Receives Regenerative Medicine Advanced Therapy Designation from FDA for Ilixadencel in Kidney Cancer Immunicum AB (publ; IMMU.ST) announced today that it has received Regenerative Medicine Advanced ...
- Infiniti’s Industry Experts Examine Regenerative Medicine Manufacturing Challengeson May 5, 2020 at 1:07 pm
Infiniti Research has recently announced the completion of its latest article - regenerative medicine manufacturing challenges.
- Would an NBA 'bubble city' actually work? This sports medicine expert says yeson May 4, 2020 at 11:19 am
As many NBA teams weigh re-opening team facilities while the coronavirus pandemic continues, a lingering question remains: Can the league find a way back to safely playing games in the ...
- Nanostimulators can amp up stem cells' regenerative powers for muscle repairon May 3, 2020 at 1:05 pm
In regenerative medicine, an ideal treatment for patients whose muscles are damaged from lack of oxygen would be to invigorate them with an injection of their own stem cells.
- Overcoming kidney organoid challenges for regenerative medicineon May 1, 2020 at 8:44 pm
Kidney organoids derived from human induced pluripotent stem cells bear the potential to be used as a regenerative medicine r. Advances in developmental bi ...
- 2020 Global Regenerative Medicine Market Report with Geographic and Technological Segmentationon April 29, 2020 at 2:51 pm
The "Regenerative Medicine Market by Technology and Geography - Forecast and Analysis 2020-2024" report has been added to ResearchAndMarkets.com's offering.
via Google News and Bing News